Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance
Bettina Hohberger, Harald Prüß, Christian Yahya Mardin, Robert Lämmer, Johannes Müller, Gerd Wallukat
This study investigates autoimmune phenomena targeting the β2-AR in Alzheimer's Disease patients, finding that long-chain Aβ peptides activate the β2-AR and that AD patients have functional autoantibodies similar to those in glaucoma.
PLoS ONE · Oct 6, 2022Peer-reviewedNeuroscience